• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[非缺血性心肌病的风险分层:病例报告——病例5/2010]

[Risk stratification in non ischemic cardiomyopathy: a case report--Case 5/2010].

作者信息

Parade U, Klingel K, Kandolf R, Gawaz M, Schreieck J

机构信息

Abteilung für Kardiologie, Medizinische Universitätsklink Tübingen.

出版信息

Dtsch Med Wochenschr. 2010 Jun;135(22):1122. doi: 10.1055/s-0030-1247612. Epub 2010 May 31.

DOI:10.1055/s-0030-1247612
PMID:20514634
Abstract

HISTORY AND ADMISSION FINDINGS

A 65-year-old male patient with rapid increasing shortness of breath and newly diagnosed atrial fibrillation was admitted to our hospital.

INVESTIGATIONS

The ECG revealed atrial fibrillation. Echocardiography showed severe decreased left ventricular function. The magnetic resonance imaging (MRI) scan confirmed the severe reduced left ventricular function with a two graded mitral regurgitation as well as a pronounced late enhancement in the posterobasal area of the interventricular septum. Cardiac catheterisation showed mild diffuse atherosclerosis of the coronary arteries without stenotic lesions. Multiple myocardial biopsies of the right ventricle revealed extensive remodelling processes with focal fibrosis in presence of mononuclear cell infiltrates, T-wave alternans and the heart rate variability were positive.

DIAGNOSIS, TREATMENT AND COURSE: Nonischaemic cardiomyopathy (NICM) with severe reduced left ventriucular function was diagnosed. After successful electrical cardioversion and initiation of a sufficient heart failure treatment, the clinical symptoms as well as left ventricular function improved significantly.

CONCLUSION

Risk stratification of sudden cardiac death remains a clinical challenge especially in NICM. Significantly predictors in ischaemic cardiomyopathy, such as heart rate turbulance (HRT) and T-wave alternans, are not useful or have no importance in NICM. However, the prognosis does not correlate with restricted left ventricular function in NICM. Cardiac MRI or marker of autonomic dysfunction could be helpful in risk stratification. How far late enhancement is a surrogate parameter or the real substrate for life threatening arrhythmias is still unclear. Non-invasive risk stratification could be helpful in borderline decisions, however, it should not be taken mandatory. Close-meshed control intervals of the clinical status under optimal medication are recommended, followed by a implantation of an implantable cardioverter-defibrillator (ICD) if needed. ICD implantation is superior to medical treatment in persistent depressed left ventricular function. The ideal time for ICD implantation in newly diagnosed NICM remains unclear at the moment.

摘要

病史及入院检查结果

一名65岁男性患者,因呼吸急促迅速加重且新诊断为房颤入住我院。

检查

心电图显示房颤。超声心动图显示左心室功能严重下降。磁共振成像(MRI)扫描证实左心室功能严重降低,伴有二尖瓣反流二级以及室间隔后基底区域明显延迟强化。心脏导管检查显示冠状动脉轻度弥漫性动脉粥样硬化,无狭窄病变。右心室多次心肌活检显示广泛的重塑过程,伴有局灶性纤维化及单核细胞浸润,T波交替和心率变异性均为阳性。

诊断、治疗及病程:诊断为非缺血性心肌病(NICM),左心室功能严重降低。成功进行电复律并开始充分的心力衰竭治疗后,临床症状及左心室功能显著改善。

结论

心脏性猝死的风险分层仍然是一项临床挑战,尤其是在NICM中。缺血性心肌病中的重要预测指标,如心率震荡(HRT)和T波交替,在NICM中无用或不重要。然而,NICM的预后与左心室功能受限无关。心脏MRI或自主神经功能障碍标志物可能有助于风险分层。延迟强化在多大程度上是危及生命心律失常的替代参数或真正基质仍不清楚。非侵入性风险分层在临界决策中可能有用,但不应强制采用。建议在最佳药物治疗下密切监测临床状态,必要时植入植入式心脏复律除颤器(ICD)。在左心室功能持续低下时,ICD植入优于药物治疗。目前新诊断NICM中ICD植入的理想时间仍不清楚。

相似文献

1
[Risk stratification in non ischemic cardiomyopathy: a case report--Case 5/2010].[非缺血性心肌病的风险分层:病例报告——病例5/2010]
Dtsch Med Wochenschr. 2010 Jun;135(22):1122. doi: 10.1055/s-0030-1247612. Epub 2010 May 31.
2
Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.用对比增强磁共振成像评估的梗死组织异质性可预测缺血性心肌病和植入式心律转复除颤器患者的自发性室性心律失常。
Circ Cardiovasc Imaging. 2009 May;2(3):183-90. doi: 10.1161/CIRCIMAGING.108.826529. Epub 2009 Mar 23.
3
Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death.心肌纤维化可预测植入式心脏复律除颤器治疗用于一级预防心源性猝死的患者中的适当设备治疗。
J Am Coll Cardiol. 2011 Feb 15;57(7):821-8. doi: 10.1016/j.jacc.2010.06.062.
4
Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.非侵入性风险分层可预防肥厚型心肌病患者因阵发性心房颤动导致的猝死。
J Cardiovasc Med (Hagerstown). 2006 Sep;7(9):711-3. doi: 10.2459/01.JCM.0000243007.97793.0f.
5
[Arrhythmogenic right ventricular dysplasia as a cause of "sudden cardiac death" with survival].致心律失常性右室发育不良作为“心脏性猝死”伴生存的病因
Dtsch Med Wochenschr. 2003 Feb 14;128(7):317-20. doi: 10.1055/s-2003-37245.
6
Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study.特发性扩张型心肌病的无创性心律失常风险分层:马尔堡心肌病研究结果
Circulation. 2003 Dec 9;108(23):2883-91. doi: 10.1161/01.CIR.0000100721.52503.85. Epub 2003 Nov 17.
7
[Interventional treatment in hypertrophic cardiomyopathy].[肥厚型心肌病的介入治疗]
Herz. 2005 Mar;30(2):102-10. doi: 10.1007/s00059-005-2675-8.
8
Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy.微伏级T波交替在缺血性心肌病患者危险分层中的预后价值
J Am Coll Cardiol. 2006 May 2;47(9):1820-7. doi: 10.1016/j.jacc.2005.11.079. Epub 2006 Apr 19.
9
The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention.ABCD(心脏复律除颤器前交替现象)试验:利用T波交替现象提高心脏性猝死预防效率的策略。
J Am Coll Cardiol. 2009 Feb 10;53(6):471-9. doi: 10.1016/j.jacc.2008.08.077.
10
Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum.微伏级T波交替变化可区分可能从植入式心脏除颤器治疗中获益和不太可能获益的患者:多中心自动除颤器植入试验(MADIT)II难题的解决方案。
Circulation. 2004 Oct 5;110(14):1885-9. doi: 10.1161/01.CIR.0000143160.14610.53. Epub 2004 Sep 27.